home / stock / sybx / sybx news

SYBX News and Press, Synlogic Inc. From 11/07/23

Stock Information
Company Name: Synlogic Inc.
Stock Symbol: SYBX
Market: NASDAQ
Website: synlogictx.com
Menu
SYBX SYBX Quote SYBX Short SYBX News SYBX Articles SYBX Message Board
Get SYBX Alerts

News, Short Squeeze, Breakout and More Instantly...
SYBX - Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration

CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, announced today that it has achieved its third pre-specified resear...
SYBX - ENGN, XLO and BDRX among mid-day movers

2023-11-06 12:51:18 ET Gainers: MSP Recovery ( LIFW ) +458% . Bluegreen Vacations Holding Corporation ( BVH ) +106% . Tenon Medical ( TNON ) +72% . Cano Health ( CANO ) +43% . Cheetah Net Supply Chain Service ( CTNT ) +36% . ...

SYBX - Synlogic Announces Closing of $21.0 Million Underwritten Public Offering

CAMBRIDGE, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today announced the closing of its previously announced underwritte...

SYBX - Synlogic down 4%, priced $21M offering

2023-09-29 07:39:46 ET More on Synlogic Synlogic announces 1-for-15 reverse stock split Synlogic spikes on FDA Fast Track tag for metabolic disorder therapy Seeking Alpha’s Quant Rating on Synlogic Historical earnings data for Synlogic For furt...
SYBX - Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering

CAMBRIDGE, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today announced the pricing of an underwritten public offering of ...

SYBX - VCNX, GCT and ACIC among mid-day movers

2023-09-28 12:59:55 ET Gainers: Baudax Bio ( BXRX ) +75% . Chico's Fas ( CHS ) +63% . Aytu BioPharma ( AYTU ) +35% . Axcella Health ( AXLA ) +35% . Vaccinex ( VCNX ) +33% . Organogenesis Holdings ( ORGO ) +27% . F...

SYBX - Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolism

CAMBRIDGE, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today announced the publication of results from its Synpheny-1 Pha...
SYBX - Synlogic announces 1-for-15 reverse stock split

2023-09-27 13:20:31 ET More on Synlogic Synlogic spikes on FDA Fast Track tag for metabolic disorder therapy Seeking Alpha’s Quant Rating on Synlogic Historical earnings data for Synlogic Financial information for Synlogic For further details s...

SYBX - Synlogic Announces Reverse Stock Split

CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today announced that it will implement a 1-for-15 Reverse Stock Sp...

SYBX - Synlogic to Participate in Chardan's Genetic Medicines Conference

CAMBRIDGE, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today announced its management team will participate in Chardan&#x...
Previous 10 Next 10